Lecap Asset Management Ltd. acquired a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 72,873 shares of the real estate investment trust’s stock, valued at approximately $1,667,000.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Rise Advisors LLC bought a new stake in shares of Healthpeak Properties during the third quarter valued at approximately $29,000. Riverview Trust Co purchased a new position in Healthpeak Properties during the third quarter valued at $35,000. UMB Bank n.a. bought a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $40,000. Mather Group LLC. purchased a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $60,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Healthpeak Properties in the 2nd quarter worth about $66,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Trading Up 3.1 %
NYSE:DOC opened at $23.12 on Thursday. The company has a market cap of $16.27 billion, a PE ratio of 66.06, a price-to-earnings-growth ratio of 2.27 and a beta of 1.14. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.91. The company has a 50 day simple moving average of $22.21 and a two-hundred day simple moving average of $20.62. Healthpeak Properties, Inc. has a 12 month low of $15.24 and a 12 month high of $23.15.
Wall Street Analysts Forecast Growth
DOC has been the topic of a number of recent research reports. Citigroup upped their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Royal Bank of Canada raised their price objective on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research report on Tuesday, July 30th. Scotiabank boosted their target price on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a report on Monday, September 9th. Wedbush raised their price target on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a report on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and upped their price target for the stock from $20.00 to $28.00 in a research note on Monday. One research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Healthpeak Properties currently has an average rating of “Moderate Buy” and an average price target of $22.62.
View Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also
- Five stocks we like better than Healthpeak Properties
- How is Compound Interest Calculated?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- There Are Different Types of Stock To Invest In
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- EV Stocks and How to Profit from Them
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.